Toll-like receptor 2 confers partial neuroprotection during prion disease
Neuroinflammation and neurodegeneration are common during prion infection, but the mechanisms that underlie these pathological features are not well understood. Several components of innate immunity, such as Toll-like receptor (TLR) 4 and Complement C1q, have been shown to influence prion disease. T...
Gespeichert in:
Veröffentlicht in: | PloS one 2018-12, Vol.13 (12), p.e0208559-e0208559 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0208559 |
---|---|
container_issue | 12 |
container_start_page | e0208559 |
container_title | PloS one |
container_volume | 13 |
creator | Carroll, James A Race, Brent Williams, Katie Chesebro, Bruce |
description | Neuroinflammation and neurodegeneration are common during prion infection, but the mechanisms that underlie these pathological features are not well understood. Several components of innate immunity, such as Toll-like receptor (TLR) 4 and Complement C1q, have been shown to influence prion disease. To identify additional components of innate immunity that might impact prion disease within the central nervous system (CNS), we screened RNA from brains of pre-clinical and clinical 22L-infected mice for alterations in genes associated with innate immunity. Transcription of several genes encoding damage-associated molecular pattern (DAMP) proteins and receptors were increased in the brains of prion-infected mice. To investigate the role of some of these proteins in prion disease of the CNS, we infected mice deficient in DAMP receptor genes Tlr2, C3ar1, and C5ar1 with 22L scrapie. Elimination of TLR2 accelerated disease by a median of 10 days, while lack of C3aR1 or C5aR1 had no effect on disease tempo. Histopathologically, all knockout mouse strains tested were similar to infected control mice in gliosis, vacuolation, and PrPSc deposition. Analysis of proinflammatory markers in the brains of infected knockout mice indicated only a few alterations in gene expression suggesting that C5aR1 and TLR2 signaling did not act synergistically in the brains of prion-infected mice. These results indicate that signaling through TLR2 confers partial neuroprotection during prion infection. |
doi_str_mv | 10.1371/journal.pone.0208559 |
format | Article |
fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2161935612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9c73cd3201ab40c2ad32d80732ee0bec</doaj_id><sourcerecordid>2162495145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-f56d2bb645d8988c933e95ccd61eb67fd5ff0edc1d8f043f73f5911addb324bb3</originalsourceid><addsrcrecordid>eNptUstu1DAUjRCIPuAPEERi002mfsROvEFCVQsjVWLTri0_rocMHjvYSSX-Hs9MWrWIla_tc889xz5V9QGjFaYdvtzGOQXlV2MMsEIE9YyJV9UpFpQ0nCD6-ll9Up3lvEWI0Z7zt9UJRUxwzvBptb6L3jd--AV1AgPjFFNNahODg5TrUaVpUL4OMKc4pjiBmYYYajunIWzqMR02QwaV4V31ximf4f2ynlf3N9d3V9-b2x_f1ldfbxvDCJ8ax7glWvOW2V70vRGUgmDGWI5B885Z5hwCa7DtHWqp66hjAmNlraak1ZqeV5-OvKOPWS6vkCXBvNhlHJOCWB8RNqqtLCJ3Kv2RUQ3ycBDTRu59GQ9SmI4aSwnCSrfIEFVq26OOEgCkwRSuL8u0We-KLAhTUv4F6cubMPyUm_ggOcWkfEohuFgIUvw9Q57kbsgGvFcB4nzQTVrBcMsK9PM_0P-7a48ok2LOCdyTGIzkPhmPXXKfDLkko7R9fG7kqekxCvQvNT24gQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2161935612</pqid></control><display><type>article</type><title>Toll-like receptor 2 confers partial neuroprotection during prion disease</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Carroll, James A ; Race, Brent ; Williams, Katie ; Chesebro, Bruce</creator><creatorcontrib>Carroll, James A ; Race, Brent ; Williams, Katie ; Chesebro, Bruce</creatorcontrib><description>Neuroinflammation and neurodegeneration are common during prion infection, but the mechanisms that underlie these pathological features are not well understood. Several components of innate immunity, such as Toll-like receptor (TLR) 4 and Complement C1q, have been shown to influence prion disease. To identify additional components of innate immunity that might impact prion disease within the central nervous system (CNS), we screened RNA from brains of pre-clinical and clinical 22L-infected mice for alterations in genes associated with innate immunity. Transcription of several genes encoding damage-associated molecular pattern (DAMP) proteins and receptors were increased in the brains of prion-infected mice. To investigate the role of some of these proteins in prion disease of the CNS, we infected mice deficient in DAMP receptor genes Tlr2, C3ar1, and C5ar1 with 22L scrapie. Elimination of TLR2 accelerated disease by a median of 10 days, while lack of C3aR1 or C5aR1 had no effect on disease tempo. Histopathologically, all knockout mouse strains tested were similar to infected control mice in gliosis, vacuolation, and PrPSc deposition. Analysis of proinflammatory markers in the brains of infected knockout mice indicated only a few alterations in gene expression suggesting that C5aR1 and TLR2 signaling did not act synergistically in the brains of prion-infected mice. These results indicate that signaling through TLR2 confers partial neuroprotection during prion infection.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0208559</identifier><identifier>PMID: 30596651</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Alzheimer's disease ; Anaphylatoxins - analysis ; Animals ; Biology and Life Sciences ; Brain ; Brain - metabolism ; Brain - pathology ; Central nervous system ; Chemokines - metabolism ; Complement component C1q ; Complement System Proteins - metabolism ; Cytokines - metabolism ; Damage patterns ; Disease Susceptibility ; Gene Expression ; Genes ; Gliosis ; Immune system ; Immunity ; Immunity, Innate - genetics ; Immunology ; Infections ; Infectious diseases ; Inflammation ; Innate immunity ; Laboratory animals ; Medicine and Health Sciences ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Nervous system ; Neurodegeneration ; Neuroprotection ; Pathogenesis ; Prion Diseases - metabolism ; Prion Diseases - pathology ; Prion Diseases - veterinary ; Prions ; Proteins ; Receptor, Anaphylatoxin C5a - deficiency ; Receptor, Anaphylatoxin C5a - genetics ; Receptor, Anaphylatoxin C5a - metabolism ; Receptors ; Receptors, Complement - deficiency ; Receptors, Complement - genetics ; Receptors, Complement - metabolism ; Ribonucleic acid ; RNA ; RNA - genetics ; RNA - metabolism ; Rodents ; Scrapie ; Sepsis ; Severity of Illness Index ; Signal Transduction ; Signaling ; TLR2 protein ; Toll-Like Receptor 2 - deficiency ; Toll-Like Receptor 2 - genetics ; Toll-Like Receptor 2 - metabolism ; Toll-like receptors ; Transcription</subject><ispartof>PloS one, 2018-12, Vol.13 (12), p.e0208559-e0208559</ispartof><rights>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-f56d2bb645d8988c933e95ccd61eb67fd5ff0edc1d8f043f73f5911addb324bb3</citedby><cites>FETCH-LOGICAL-c526t-f56d2bb645d8988c933e95ccd61eb67fd5ff0edc1d8f043f73f5911addb324bb3</cites><orcidid>0000-0003-4329-1488</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312208/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312208/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30596651$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carroll, James A</creatorcontrib><creatorcontrib>Race, Brent</creatorcontrib><creatorcontrib>Williams, Katie</creatorcontrib><creatorcontrib>Chesebro, Bruce</creatorcontrib><title>Toll-like receptor 2 confers partial neuroprotection during prion disease</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Neuroinflammation and neurodegeneration are common during prion infection, but the mechanisms that underlie these pathological features are not well understood. Several components of innate immunity, such as Toll-like receptor (TLR) 4 and Complement C1q, have been shown to influence prion disease. To identify additional components of innate immunity that might impact prion disease within the central nervous system (CNS), we screened RNA from brains of pre-clinical and clinical 22L-infected mice for alterations in genes associated with innate immunity. Transcription of several genes encoding damage-associated molecular pattern (DAMP) proteins and receptors were increased in the brains of prion-infected mice. To investigate the role of some of these proteins in prion disease of the CNS, we infected mice deficient in DAMP receptor genes Tlr2, C3ar1, and C5ar1 with 22L scrapie. Elimination of TLR2 accelerated disease by a median of 10 days, while lack of C3aR1 or C5aR1 had no effect on disease tempo. Histopathologically, all knockout mouse strains tested were similar to infected control mice in gliosis, vacuolation, and PrPSc deposition. Analysis of proinflammatory markers in the brains of infected knockout mice indicated only a few alterations in gene expression suggesting that C5aR1 and TLR2 signaling did not act synergistically in the brains of prion-infected mice. These results indicate that signaling through TLR2 confers partial neuroprotection during prion infection.</description><subject>Alzheimer's disease</subject><subject>Anaphylatoxins - analysis</subject><subject>Animals</subject><subject>Biology and Life Sciences</subject><subject>Brain</subject><subject>Brain - metabolism</subject><subject>Brain - pathology</subject><subject>Central nervous system</subject><subject>Chemokines - metabolism</subject><subject>Complement component C1q</subject><subject>Complement System Proteins - metabolism</subject><subject>Cytokines - metabolism</subject><subject>Damage patterns</subject><subject>Disease Susceptibility</subject><subject>Gene Expression</subject><subject>Genes</subject><subject>Gliosis</subject><subject>Immune system</subject><subject>Immunity</subject><subject>Immunity, Innate - genetics</subject><subject>Immunology</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Inflammation</subject><subject>Innate immunity</subject><subject>Laboratory animals</subject><subject>Medicine and Health Sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Nervous system</subject><subject>Neurodegeneration</subject><subject>Neuroprotection</subject><subject>Pathogenesis</subject><subject>Prion Diseases - metabolism</subject><subject>Prion Diseases - pathology</subject><subject>Prion Diseases - veterinary</subject><subject>Prions</subject><subject>Proteins</subject><subject>Receptor, Anaphylatoxin C5a - deficiency</subject><subject>Receptor, Anaphylatoxin C5a - genetics</subject><subject>Receptor, Anaphylatoxin C5a - metabolism</subject><subject>Receptors</subject><subject>Receptors, Complement - deficiency</subject><subject>Receptors, Complement - genetics</subject><subject>Receptors, Complement - metabolism</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA - genetics</subject><subject>RNA - metabolism</subject><subject>Rodents</subject><subject>Scrapie</subject><subject>Sepsis</subject><subject>Severity of Illness Index</subject><subject>Signal Transduction</subject><subject>Signaling</subject><subject>TLR2 protein</subject><subject>Toll-Like Receptor 2 - deficiency</subject><subject>Toll-Like Receptor 2 - genetics</subject><subject>Toll-Like Receptor 2 - metabolism</subject><subject>Toll-like receptors</subject><subject>Transcription</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptUstu1DAUjRCIPuAPEERi002mfsROvEFCVQsjVWLTri0_rocMHjvYSSX-Hs9MWrWIla_tc889xz5V9QGjFaYdvtzGOQXlV2MMsEIE9YyJV9UpFpQ0nCD6-ll9Up3lvEWI0Z7zt9UJRUxwzvBptb6L3jd--AV1AgPjFFNNahODg5TrUaVpUL4OMKc4pjiBmYYYajunIWzqMR02QwaV4V31ximf4f2ynlf3N9d3V9-b2x_f1ldfbxvDCJ8ax7glWvOW2V70vRGUgmDGWI5B885Z5hwCa7DtHWqp66hjAmNlraak1ZqeV5-OvKOPWS6vkCXBvNhlHJOCWB8RNqqtLCJ3Kv2RUQ3ycBDTRu59GQ9SmI4aSwnCSrfIEFVq26OOEgCkwRSuL8u0We-KLAhTUv4F6cubMPyUm_ggOcWkfEohuFgIUvw9Q57kbsgGvFcB4nzQTVrBcMsK9PM_0P-7a48ok2LOCdyTGIzkPhmPXXKfDLkko7R9fG7kqekxCvQvNT24gQ</recordid><startdate>20181231</startdate><enddate>20181231</enddate><creator>Carroll, James A</creator><creator>Race, Brent</creator><creator>Williams, Katie</creator><creator>Chesebro, Bruce</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4329-1488</orcidid></search><sort><creationdate>20181231</creationdate><title>Toll-like receptor 2 confers partial neuroprotection during prion disease</title><author>Carroll, James A ; Race, Brent ; Williams, Katie ; Chesebro, Bruce</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-f56d2bb645d8988c933e95ccd61eb67fd5ff0edc1d8f043f73f5911addb324bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Alzheimer's disease</topic><topic>Anaphylatoxins - analysis</topic><topic>Animals</topic><topic>Biology and Life Sciences</topic><topic>Brain</topic><topic>Brain - metabolism</topic><topic>Brain - pathology</topic><topic>Central nervous system</topic><topic>Chemokines - metabolism</topic><topic>Complement component C1q</topic><topic>Complement System Proteins - metabolism</topic><topic>Cytokines - metabolism</topic><topic>Damage patterns</topic><topic>Disease Susceptibility</topic><topic>Gene Expression</topic><topic>Genes</topic><topic>Gliosis</topic><topic>Immune system</topic><topic>Immunity</topic><topic>Immunity, Innate - genetics</topic><topic>Immunology</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Inflammation</topic><topic>Innate immunity</topic><topic>Laboratory animals</topic><topic>Medicine and Health Sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Nervous system</topic><topic>Neurodegeneration</topic><topic>Neuroprotection</topic><topic>Pathogenesis</topic><topic>Prion Diseases - metabolism</topic><topic>Prion Diseases - pathology</topic><topic>Prion Diseases - veterinary</topic><topic>Prions</topic><topic>Proteins</topic><topic>Receptor, Anaphylatoxin C5a - deficiency</topic><topic>Receptor, Anaphylatoxin C5a - genetics</topic><topic>Receptor, Anaphylatoxin C5a - metabolism</topic><topic>Receptors</topic><topic>Receptors, Complement - deficiency</topic><topic>Receptors, Complement - genetics</topic><topic>Receptors, Complement - metabolism</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA - genetics</topic><topic>RNA - metabolism</topic><topic>Rodents</topic><topic>Scrapie</topic><topic>Sepsis</topic><topic>Severity of Illness Index</topic><topic>Signal Transduction</topic><topic>Signaling</topic><topic>TLR2 protein</topic><topic>Toll-Like Receptor 2 - deficiency</topic><topic>Toll-Like Receptor 2 - genetics</topic><topic>Toll-Like Receptor 2 - metabolism</topic><topic>Toll-like receptors</topic><topic>Transcription</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carroll, James A</creatorcontrib><creatorcontrib>Race, Brent</creatorcontrib><creatorcontrib>Williams, Katie</creatorcontrib><creatorcontrib>Chesebro, Bruce</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carroll, James A</au><au>Race, Brent</au><au>Williams, Katie</au><au>Chesebro, Bruce</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toll-like receptor 2 confers partial neuroprotection during prion disease</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2018-12-31</date><risdate>2018</risdate><volume>13</volume><issue>12</issue><spage>e0208559</spage><epage>e0208559</epage><pages>e0208559-e0208559</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Neuroinflammation and neurodegeneration are common during prion infection, but the mechanisms that underlie these pathological features are not well understood. Several components of innate immunity, such as Toll-like receptor (TLR) 4 and Complement C1q, have been shown to influence prion disease. To identify additional components of innate immunity that might impact prion disease within the central nervous system (CNS), we screened RNA from brains of pre-clinical and clinical 22L-infected mice for alterations in genes associated with innate immunity. Transcription of several genes encoding damage-associated molecular pattern (DAMP) proteins and receptors were increased in the brains of prion-infected mice. To investigate the role of some of these proteins in prion disease of the CNS, we infected mice deficient in DAMP receptor genes Tlr2, C3ar1, and C5ar1 with 22L scrapie. Elimination of TLR2 accelerated disease by a median of 10 days, while lack of C3aR1 or C5aR1 had no effect on disease tempo. Histopathologically, all knockout mouse strains tested were similar to infected control mice in gliosis, vacuolation, and PrPSc deposition. Analysis of proinflammatory markers in the brains of infected knockout mice indicated only a few alterations in gene expression suggesting that C5aR1 and TLR2 signaling did not act synergistically in the brains of prion-infected mice. These results indicate that signaling through TLR2 confers partial neuroprotection during prion infection.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>30596651</pmid><doi>10.1371/journal.pone.0208559</doi><orcidid>https://orcid.org/0000-0003-4329-1488</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2018-12, Vol.13 (12), p.e0208559-e0208559 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2161935612 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
subjects | Alzheimer's disease Anaphylatoxins - analysis Animals Biology and Life Sciences Brain Brain - metabolism Brain - pathology Central nervous system Chemokines - metabolism Complement component C1q Complement System Proteins - metabolism Cytokines - metabolism Damage patterns Disease Susceptibility Gene Expression Genes Gliosis Immune system Immunity Immunity, Innate - genetics Immunology Infections Infectious diseases Inflammation Innate immunity Laboratory animals Medicine and Health Sciences Mice Mice, Inbred C57BL Mice, Knockout Nervous system Neurodegeneration Neuroprotection Pathogenesis Prion Diseases - metabolism Prion Diseases - pathology Prion Diseases - veterinary Prions Proteins Receptor, Anaphylatoxin C5a - deficiency Receptor, Anaphylatoxin C5a - genetics Receptor, Anaphylatoxin C5a - metabolism Receptors Receptors, Complement - deficiency Receptors, Complement - genetics Receptors, Complement - metabolism Ribonucleic acid RNA RNA - genetics RNA - metabolism Rodents Scrapie Sepsis Severity of Illness Index Signal Transduction Signaling TLR2 protein Toll-Like Receptor 2 - deficiency Toll-Like Receptor 2 - genetics Toll-Like Receptor 2 - metabolism Toll-like receptors Transcription |
title | Toll-like receptor 2 confers partial neuroprotection during prion disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A51%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toll-like%20receptor%202%20confers%20partial%20neuroprotection%20during%20prion%20disease&rft.jtitle=PloS%20one&rft.au=Carroll,%20James%20A&rft.date=2018-12-31&rft.volume=13&rft.issue=12&rft.spage=e0208559&rft.epage=e0208559&rft.pages=e0208559-e0208559&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0208559&rft_dat=%3Cproquest_plos_%3E2162495145%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2161935612&rft_id=info:pmid/30596651&rft_doaj_id=oai_doaj_org_article_9c73cd3201ab40c2ad32d80732ee0bec&rfr_iscdi=true |